DarioHealth Corp. (DRIO)
$6.77+$0.00 (+0.00%) Today
Adam K. Stern - DirectorDarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. The company vertically integrated a health intelligence platform with a mission to power the behavior changes that drive greater health. Unlike software-only digital health platforms, Dario owns the complete chain of value in chronic care management - connected FDA-cleared hardware devices that generate continuous physiological data, and AI built on that proprietary data. The company focuses on delivering user experiences, longer sustained engagement, and stronger clinical outcomes, at affordable prices, which then delivers the highest return on investment in the industry.
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market purchase | 1 | 14,430 | $100K |
| Other acquisition / disposition | 2 | 1,015 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
12 Form 4 filings on record, the earliest from Nov 14, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Dennis Matheis - Director | Other | Series B-2 Preferred Stock | 50 | $20,000.00 | $50K | |
| Dennis Matheis - Director | Other | Common Stock | 965 | $382.00 | $18K | |
| Dennis Matheis - Director | Open-market purchase | Common Stock | 14,430 | $6.93 | $100K | |
| Adam K. Stern - Director | Grant or award | Common Stock | 20,000 | $0.00 | - | |
| Chen Franco-Yehuda - Officer | Grant or award | Common Stock | 5,000 | $0.00 | - | |
| Yoav Shaked - Director | Grant or award | Common Stock | 20,000 | $0.00 | - | |
| Steven Charles Nelson - Officer | Grant or award | Common Stock | 30,000 | $0.00 | - | |
| Dennis M. McGrath - Director | Grant or award | Common Stock | 20,000 | $0.00 | - | |
| Erez Raphael - Officer | Grant or award | Common Stock | 60,000 | $0.00 | - | |
| Lawrence B. Leisure - Director | Grant or award | Common Stock | 20,000 | $0.00 | - | |
| Hila Karah - Director | Grant or award | Common Stock | 20,000 | $0.00 | - | |
| Dennis Matheis - Director | Grant or award | Common Stock | 20,000 | $0.00 | - | |
| Steven Charles Nelson - Officer | Open-market purchase | Common Stock | 40,000 | $10.60 | $21K | |
| Steven Charles Nelson - Officer | Open-market purchase | Common Stock | 5,000 | $18.18 | $5K |
DarioHealth Corp. (DRIO) had 1 insider filing in the last 90 days, with the most recent on 2026-07-28. The full record for DRIO runs to 12 Form 4 filings, the earliest from 2024-11-14. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
1 insider purchase of DRIO was filed in the last 90 days, totaling $100K.
No insider sales of DRIO were filed in the last 90 days.
This page tracks DRIO Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add DRIO to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
